المؤلفون: Martin-Broto J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain. jmartin@atbsarc.org.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Av. de los Reyes Católicos, 2, 28040, Madrid, Spain. jmartin@atbsarc.org.; General de Villalba University Hospital, 28400, Madrid, Spain. jmartin@atbsarc.org., Valverde C; Medical Oncology department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain., Hindi N; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain.; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Av. de los Reyes Católicos, 2, 28040, Madrid, Spain.; General de Villalba University Hospital, 28400, Madrid, Spain., Vincenzi B; Medical Oncology, University Campus Bio-Medico and Fondazione Policlinico Universitario Campus Bio-Medico, 00128, Rome, Italy., Martinez-Trufero J; Medical Oncology Department, University Hospital Miguel Servet, 50009, Zaragoza, Spain., Grignani G; Medical Oncology Unit, Città della Salute e della Scienza Hospital, 10126, Turin, Italy., Italiano A; Medical Oncology department, Institute Bergonié, 33076, Bordeaux, France., Lavernia J; Medical Oncology department, Fundación Instituto Valenciano de Oncologia, 46009, Valencia, Spain., Vallejo A; Pathology department, Hospital Regional Universitario de Malaga, 29010, Malaga, Spain., Tos PD; Department of Medicine, School of Medicine, University of Padua, 35122, Padua, Italy., Le Loarer F; Pathology department, Institute Bergonié, 33076, Bordeaux, France., Gonzalez-Campora R; Pathology department, Hospital Quironsalud, 14004, Cordoba, Cordoba, Spain., Ramos R; Pathology department, University Hospital Son Espases, 07120, Mallorca, Spain., Hernández-Jover D; Radiology department, Sant Pau University Hospital, 08025, Barcelona, Spain., Gutierrez A; Hematology department, University Hospital Son Espases, 07120, Mallorca, Spain., Serrano C; Medical Oncology department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain., Monteagudo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Letón R; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain., Robledo M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain., Moura DS; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain., Martin-Ruiz M; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain., López-Guerrero JA; Molecular Biology department, Fundación Instituto Valenciano de Oncologia, 46009, Valencia, Spain., Cruz J; Pathology department, Fundación Instituto Valenciano de Oncologia, 46009, Valencia, Spain., Fernandez-Serra A; Molecular Biology department, Fundación Instituto Valenciano de Oncologia, 46009, Valencia, Spain., Blay JY; Medicine Department, Centre Léon Bérard, 69008, Lyon, France., Fumagalli E; Medicine Department, Fondazione IRCCS - Istituto Nazionale dei Tumori, 20133, Milan, Italy., Martinez-Marin V; Department of Medical Oncology, Hospital Universitario La Paz-IdiPAZ, P. Castellana, 261, 28046, Madrid, Spain.

المصدر: Molecular cancer [Mol Cancer] 2023 Aug 09; Vol. 22 (1), pp. 127. Date of Electronic Publication: 2023 Aug 09.

نوع المنشور: Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , Gastrointestinal Stromal Tumors*/drug therapy , Gastrointestinal Stromal Tumors*/genetics , Sarcoma*/drug therapy, Adult ; Humans ; Mutation ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins c-kit/genetics

المؤلفون: Maurel J; Department of Medical Oncology, Hospital Clinic, CIBERehd, Translational Genomics and Targeted Therapeutics in Solid Tumors (IDIBAPS), Barcelona, Spain., López-Pousa A; Department of Medical Oncology, Hospital Universitario Sant Pau, Barcelona, Spain., Calabuig S; Molecular Oncology Laboratory, Fundación de Investigación del Hospital General Universitario de Valencia, Valencia, Spain., Bagué S; Pathology Department, Hospital Universitario Sant Pau, Barcelona, Spain., Del Muro XG; Department of Medical Oncology, Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain., Sanjuan X; Pathology Department, Institut Català d'Oncologia L'Hospitalet, Barcelona, Spain., Rubió-Casadevall J; Department of Medical Oncology, Institut Català d'Oncologia de Girona, Girona, Spain., Cuatrecasas M; Pathology Department, Hospital Clínic, CIBERehd, IDIBAPS, Barcelona, Spain., Martinez-Trufero J; Department of Medical Oncology, Hospital Universitario Miguel Servet, Saragossa, Spain., Horndler C; Pathology Department, Hospital Universitario Miguel Servet, Saragossa, Spain., Fra J; Department of Medical Oncology, Hospital Central de Asturias, Oviedo, Spain., Valverde C; Department of Medical Oncology, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Redondo A; Hospital Universitario La Paz, Madrid, Spain., Poveda A; Department of Medical Oncology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Sevilla I; Department of Medical Oncology, Hospital Universitario Virgen de la Victoria y Regional de Málaga, Málaga, Spain., Lainez N; Department of Medical Oncology, Hospital de Navarra, Pamplona, Spain., Rubini M; Department of Experimental and Diagnostic Medicine, Department of Epidemiology, University of Ferrara (UNIFE), Emilia-Romagna, Italy., García-Albéniz X; Harvard T.H. Chan School of Public Health, Boston, MA USA., Martín-Broto J; Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain., de Alava E; Pathology Department, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.

المصدر: Clinical sarcoma research [Clin Sarcoma Res] 2016 Jun 29; Vol. 6, pp. 10. Date of Electronic Publication: 2016 Jun 29 (Print Publication: 2016).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101577890 Publication Model: eCollection Cited Medium: Print ISSN: 2045-3329 (Print) Linking ISSN: 20453329 NLM ISO Abbreviation: Clin Sarcoma Res Subsets: PubMed not MEDLINE